drugset / Trial / NCT00729222

Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503)

NCT00729222 ↗

Phase 2 Completed 60 enrolled Merck Sharp & Dohme LLC NovaCardia, Inc. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The study will estimate the effects of rolofylline, alone and in addition to loop diuretic therapy on pulmonary capillary wedge pressure and other hemodynamic parameters, in patients with heart failure and renal impairment.

Timeline

Start
2008-11
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject rolofylline Small molecule 30 mg Intravenous

Indications